Xiaolin Tong

5.3k total citations
135 papers, 3.5k citations indexed

About

Xiaolin Tong is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Xiaolin Tong has authored 135 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 35 papers in Complementary and alternative medicine and 34 papers in Pharmacology. Recurrent topics in Xiaolin Tong's work include Ginseng Biological Effects and Applications (32 papers), Pharmacological Effects of Natural Compounds (23 papers) and Traditional Chinese Medicine Analysis (20 papers). Xiaolin Tong is often cited by papers focused on Ginseng Biological Effects and Applications (32 papers), Pharmacological Effects of Natural Compounds (23 papers) and Traditional Chinese Medicine Analysis (20 papers). Xiaolin Tong collaborates with scholars based in China, United States and Denmark. Xiaolin Tong's co-authors include Linhua Zhao, Fengmei Lian, Jiaxing Tian, Qiang Zhou, Zhen Zhong, Bing Pang, Zezheng Gao, De Jin, Chengjuan Gu and Yun Guo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Xiaolin Tong

133 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Tong China 32 1.7k 761 737 650 464 135 3.5k
Fengmei Lian China 26 1.2k 0.7× 529 0.7× 373 0.5× 306 0.5× 468 1.0× 99 2.6k
Linhua Zhao China 27 1.3k 0.8× 442 0.6× 442 0.6× 380 0.6× 340 0.7× 108 2.5k
Fuer Lu China 31 1.4k 0.8× 279 0.4× 502 0.7× 921 1.4× 742 1.6× 145 3.8k
Tianhua Yan China 32 1.7k 1.0× 320 0.4× 449 0.6× 511 0.8× 140 0.3× 71 3.2k
Seyed Mohammad Nabavi Iran 26 1.3k 0.8× 384 0.5× 432 0.6× 467 0.7× 326 0.7× 31 3.6k
Hui Dong China 31 1.2k 0.7× 229 0.3× 405 0.5× 635 1.0× 590 1.3× 134 3.3k
Wuwen Feng China 25 1.7k 1.0× 364 0.5× 574 0.8× 300 0.5× 110 0.2× 56 2.9k
Siwang Wang China 37 1.8k 1.0× 617 0.8× 579 0.8× 398 0.6× 331 0.7× 169 4.2k
Norio Nakamura Japan 31 1.4k 0.8× 621 0.8× 648 0.9× 820 1.3× 239 0.5× 152 3.8k

Countries citing papers authored by Xiaolin Tong

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Tong more than expected).

Fields of papers citing papers by Xiaolin Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Tong. The network helps show where Xiaolin Tong may publish in the future.

Co-authorship network of co-authors of Xiaolin Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Tong. A scholar is included among the top collaborators of Xiaolin Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Tong. Xiaolin Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yufeng, Lili Zhang, Xuemei Liu, et al.. (2024). Hirudin delays the progression of diabetic kidney disease by inhibiting glomerular endothelial cell migration and abnormal angiogenesis. Biomedicine & Pharmacotherapy. 179. 117300–117300. 4 indexed citations
2.
3.
Chen, Keyu, et al.. (2024). Dilemmas in Elderly Diabetes and Clinical Practice Involving Traditional Chinese Medicine. Pharmaceuticals. 17(7). 953–953. 1 indexed citations
4.
Gao, Zezheng, Wenhui Zhang, Lisha He, et al.. (2024). Double-blinded, randomized clinical trial of Gegen Qinlian decoction pinpointsFaecalibacteriumas key gut bacteria in alleviating hyperglycemia. Precision Clinical Medicine. 7(1). pbae003–pbae003. 11 indexed citations
5.
Chen, Keyu, Zezheng Gao, Tingting Bao, et al.. (2023). Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Communication and Signaling. 21(1). 298–298. 47 indexed citations
6.
7.
Zhou, Lijuan, et al.. (2022). Key regulators of intestinal stem cells: diet, microbiota, and microbial metabolites. Journal of genetics and genomics. 50(10). 735–746. 14 indexed citations
8.
9.
10.
Wei, Jiahua, Jiaxing Tian, Cheng Tang, et al.. (2022). The Influence of Different Types of Diabetes on Vascular Complications. Journal of Diabetes Research. 2022. 1–12. 44 indexed citations
11.
Xu, Xizhan, Zezheng Gao, Fuquan Yang, et al.. (2020). Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota are Attributable to Its Key Ingredient Berberine. Genomics Proteomics & Bioinformatics. 18(6). 721–736. 123 indexed citations
12.
Wu, Haoran, Jiaxing Tian, Jiangquan Liao, et al.. (2020). Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome. BMJ Open Diabetes Research & Care. 8(1). e001181–e001181. 11 indexed citations
13.
Han, Lin, Di Sha, Zezheng Gao, et al.. (2019). Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks. Mediators of Inflammation. 2019. 1–11. 11 indexed citations
14.
Wei, Xiuxiu, et al.. (2019). Incipient Diabetes Treated with Long-Term Classical Prescription. Journal of Diabetes Research. 2019. 1–6. 2 indexed citations
15.
Zheng, Yujiao, Lin Han, Fengmei Lian, et al.. (2019). Efficacy of Chinese Herbal Medicine in the Treatment of Moderate-Severe Painful Diabetic Peripheral Neuropathy: A Retrospective Study. Journal of Diabetes Research. 2019. 1–10. 27 indexed citations
16.
Li, Qingwei, Zezheng Gao, Han Wang, et al.. (2018). Intestinal Immunomodulatory Cells (T Lymphocytes): A Bridge between Gut Microbiota and Diabetes. Mediators of Inflammation. 2018. 1–8. 18 indexed citations
17.
Tong, Xiaolin. (2010). Effect of Tang Min Ling Pill on PPARα and Insulin Secretion. Zhongguo zhongyi jichu yixue zazhi. 2 indexed citations
18.
Tong, Xiaolin. (2010). Introduction of centipede in treatment of complications of diabetes. Zhonghua zhongyiyao zazhi. 1 indexed citations
19.
Tong, Xiaolin. (2010). Problems in diabetes treatment with traditional Chinese medicines. Zhongguo xin yao zazhi. 1 indexed citations
20.
Zhong, Zhen, et al.. (2009). Influence of Kaiyuqingre Formula on glycolipin metabolism in spontaneous obese T2DM rats.. Zhonghua zhongyiyao zazhi. 24(8). 1056–1058. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fengmei Lian Breakdown of academic impact, for papers by Linhua Zhao Breakdown of academic impact, for papers by Fuer Lu Breakdown of academic impact, for papers by Tianhua Yan Breakdown of academic impact, for papers by Seyed Mohammad Nabavi Breakdown of academic impact, for papers by Hui Dong Breakdown of academic impact, for papers by Wuwen Feng Breakdown of academic impact, for papers by Siwang Wang Breakdown of academic impact, for papers by Norio Nakamura
Rankless by CCL
2026